RHB-102 1 is a proprietary, advanced clinical-stage, once-daily, bimodal extended-release, oral tablet formulation of 5-HT3 antagonist, ondansetron, targeting oncology support, acute gastroenteritis ...
SINGAPORE, July 18 (Reuters) - RHB Singapore, part of Malaysia's fourth-biggest banking group RHB (RHBC.KL), opens new tab, will be key in driving its regional expansion plans and help meet targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results